振东制药拟3000万元参与设立基金投资于生物医药领域

Core Viewpoint - Zhendong Pharmaceutical (300158.SZ) has announced a strategic partnership with several investment institutions to enhance its competitive edge and achieve long-term investment returns in the biopharmaceutical sector [1] Group 1: Strategic Development - The company aims to leverage the strengths and resources of professional investment institutions to integrate various resources for strategic development [1] - The partnership is designed to not affect the company's daily operations and development while effectively controlling investment risks [1] Group 2: Investment Details - Zhendong Pharmaceutical will act as a limited partner, committing a capital contribution of 30 million RMB, which represents a 28.5687% stake in the partnership [1] - The primary focus of the investment will be in the biopharmaceutical field [1]